StockWatch
·
SHREE REFRIGERATIONS LTD · QQ2 FY-2027 · THE CALL

Record growth, margin pressure test credibility

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsSHREEREFShree Refrigerations Ltd04 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade C

H1 margins (13.5%) well below annual guidance (22%); relies on H2 margin spike and order pipeline realization.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong 85% revenue growth and 40% CAGR guidance backed by large Naval contracts and new market entry (data centre, Danfoss). However, H1 EBITDA margin at 13.5% vs 22% FY27 target signals margin compression from commodity inflation and skewed delivery—credibility gap of 850 bps. Management is confident but margin recovery is promised, not yet evidenced. Order book of ₹200 Cr down from ₹270 Cr start-year raises execution timing risk.

₹100 Cr

Revenue · +85% YoY

₹null Cr

Reported PAT · +null% YoY

Compressing

Margins · vs guidance: Unverified

Did the claims hold up?

Management's claims vs. the numbers

40% CAGR growth rate going forward

MET

H1 FY27: 85% YoY growth; Historical: 45% CAGR consistently

EBITDA margin 22% for FY27

OVERSTATED

H1 FY27: 13.5% (up from 11%); implies H2 must be ~28%+ to hit 22% annual

Order book sufficient to sustain guidance

Partial

INR 200 crore order book (down from INR 270 crore start of year)

Earnings quality

What changed since the last call

Deltas vs. the prior call

Order book trajectory

Downgrade

INR 270 Cr start-year → INR 200 Cr Sept; pipeline replenishment unclear. Management confident 40% CAGR sustainable but execution depends on 8 orders converting.

Margin outlook near-term

Downgrade

H1 delivered 13.5% EBITDA vs 22% FY27 guidance. Commodity inflation (copper +, geopolitical) cited as headwind; margin recovery promised in H2 but not guaranteed.

Capacity expansion

Upgrade

Unit 2 manufacturing opened (50K sq ft); 70K sq ft land leveled for further expansion. Danfoss TASP authorization granted (exclusive in India, rare globally).

Segment diversification

New

Aquilon subsidiary for sub-zero industrial chillers (chemical, food, pharma). Commercial ops start FY28; market size 'beyond few thousand crores'; management sees 'clear opportunity' for market leadership.

The Q&A

Analysts pressed hard on margins (Nishitha, Priyanshu), working capital (Siddharth), order book (multiple); management held firm on 40% CAGR but deflected on specific margin % range (deferred to 'around 22%'). Tone shifted from optimistic to defensive when questioned on commodity headwinds and H2 visibility.

The exchanges that mattered

Revenue bifurcation & product mix — Priyanshu Jain, Independent

Partial

No separate product verticals tracked; all classified as 'refrigeration vertical.' AC plant is smaller due to Navy requirement skew. H2 mix will change as orders delivered under different projects.

Data centre capabilities & opportunity — Priyanshu Jain

Partial

Capacity building ongoing (R&D, product development). No orders yet. Will import product from Australia partner initially; in-house mfg only if volume justifies. Opportunity 'huge' but timeline uncertain.

Margin trajectory & commodity hedging — Nishitha Shanklesha, ICICI Direct

Partial

H1 skewed delivery & commodity inflation (copper prices up). Strategic sourcing & inventory build mitigate. H2 will see larger operations & product mix shift driving margin improvement. Long-term margin 13-15% PAT, EBITDA ~22%.

Receivables elevation & cash cycle — Siddharth S, NAFA Asset Managers

Answered

Navy contract stage-payment structure drives elevation. Compared to Mazgoan (300+ Cr payable, 250 days), our receivables (128 Cr, 250 days) are competitive for naval segment. Target reduce to 200 days gradually.

Data centre technology & cost structure — Saurabh Singh, Value Wise Wealth

Answered

Strategic capability build. Oil-free chiller technology new to India; adoption slow. Expecting 6-8 months to 1 year for traction. Higher CapEx but recovers over 3-7 yr payback. Not included in near-term guidance.

Order book health & 40% CAGR support — Multiple

Partial

Yes, sufficient. 8 orders in pipeline. Large CCS ₹40K Cr Navy order announced; we will get portion. Pipeline conversion expected in coming months.

Asset turnover & backward integration — Komal Iyer, Institutional Investor

Answered

Assets are general-purpose, deployable across product lines. Vertical integration already at high level; raw material procured, components manufactured in-house. 'By design' asset-light model.

Working capital management & cash generation — Aditya Raval, Crescendo Capital

Answered

Strategic inventory build & receivables increase for margin & delivery support. Will turn positive by year-end as inventory depletes. Mathematics simple: if WC days improve, segment turns positive.

Depreciation change & CapEx outlook — Geetarth Tandon, Independent

Answered

Straight-line depreciation better reflects asset use (major CapEx this year at Hanbarwadi). No major fund needed for 40% growth; capex organic. New opportunities may need fund later.

Danfoss partnership revenue potential — Tushar Modi, Individual Investor

Answered

Not expecting significant revenue near-term. Strategic capability building. Danfoss very selective; we are one of 2-3 globally. Industrial cooling upside; focus on compressor service (spare parts, repair), not primary revenue yet.

Guidance

Forward guidance and management's confidence

FY27 revenue growth 40% CAGR

High

Reiterated multiple times despite H1 margin pressure. Order book ₹200 Cr & pipeline sufficient per mgmt. Historical 45% CAGR.

FY27 EBITDA margin 22%; long-term PAT margin 13-15%

Medium

H1 delivered 13.5% EBITDA (850 bps below annual target). H2 margin recovery assumed via volume scale & mix shift. Commodity headwinds (copper, metal) cited but no hedging detail.

No major CapEx needed for 40% growth; organic cash generation

Medium

Hanbarwadi facility CapEx this year large. Unit 2 opened. New opportunities may require fund raise later, but no immediate plan.

Risks the call surfaced

Ranked by how much they should concern a holder

Commodity price volatility

High

Copper & metal prices elevated; import content reduction strategy (30%+ → single digit) in progress but incomplete. Margin cushion narrow (13.5% H1 vs 22% target).

Order book & execution risk

Medium

Order book at ₹200 Cr (down from ₹270 Cr start-year). Large ₹40K Cr CCS Navy order pending government announcement. 8 orders in pipeline but conversion timeline vague.

Working capital & cash conversion

Medium

Operating cash flow negative INR -42 Cr H1 FY27. Working capital days ~400 (target 250-350). Receivables ₹128 Cr, inventory ₹80 Cr. Strategic build acknowledged but delays cash.

Data centre market adoption

Medium

Oil-free chiller technology for data centres new to India. Adoption slow; CapEx premium; payback 3-7 years. No commercial ops expected until FY28. Not included in near-term guidance.

Geopolitical & government project delays

Low

Naval projects subject to government budget cycles, elections (UP mentioned), geopolitical tensions. CCS ₹40K Cr order pending government announcement; timeline uncertain.

Management

Score 7/10. Clear on numbers (revenue, order book, margins) but vague on execution timelines (data centre, Danfoss revenue, pipeline conversion). Honest about commodity headwinds and margin compression. Transparent on working capital strategy. Some deflection on backward integration details (suggested factory visit vs direct answer). Strong track record: 45% CAGR historical, 10+ naval projects completed, ₹200 Cr+ revenue base. H1 FY27 delivery on 85% growth supports capability. H2 margin recovery promised but not yet evidenced. Working capital days elevated despite stated target; indicates execution lag on WC management.

What to watch next
  • 1 · Q3 FY27

    H2 margin recovery via higher volume and product mix shift (more HVAC/AC)

  • 2 · FY27-28

    ₹40,000 Cr CCS Navy order execution begins; largest ref plant ramp-up

  • 3 · FY28

    Data centre subsidiary (Aquilon) commercial launch; oil-free chiller sales ramp

Order book of ₹200 Cr down from ₹270 Cr start-year raises execution timing risk.

Informational and educational content only. Not investment advice.